|
|
||||||||
Ann Thorac Surg 1998;65:1574-1578
© 1998 The Society of Thoracic Surgeons
a Cardiac Transplantation and Mechanical Circulatory Assist Program, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, USA
b The Transplant Center Histocompatibility Laboratory, Cleveland Clinic Foundation, Cleveland, Ohio, USA
c Heart Failure and Cardiac Transplant Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Accepted for publication December 2, 1997.
Address reprint requests to Dr McCarthy, Department of Thoracic and Cardiovascular Surgery, Desk F25, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195
e-mail: (mccartp{at}cesmtp.ccf.org)
Background. Risk factors for death after heart transplantation (Tx) are frequently documented from multicenter registries. Although this information is helpful, it reflects a whole range of experiences and results, and may not translate to a particular center. This study was performed to (1) evaluate pre-Tx factors affecting mortality in a single-center experience, and (2) compare these factors with risk factors obtained from multicenter registry reports.
Methods. Review of our transplant database between January 1984 and December 1995 identified 405 adults who received a primary heart Tx. Multiple factors were analyzed, including demographics, Tx era, cytomegalovirus status, United Network for Organ Sharing status of recipient, presence of pulmonary hypertension, previous cardiac operations, mechanical ventilation or circulatory support, ischemia time, number of rejection episodes, and preoperative flow cytometry crossmatching.
Results. One- and 5-year survival rates were 87.8% and 73.4%, respectively (Kaplan-Meier). Contrary to multicenter registry reports, our data indicate that reoperative procedures, left ventricular assist device support, increasing donor and recipient age, and ischemia time up to 4.2 hours are not risk factors for death after Tx. Likewise, mode of donor death is not a risk factor affecting outcome. Significant risk factors for mortality identified by multivariate analysis included early transplant era (1984 to 1989; p = 0.002), female donor (p = 0.042), cytomegalovirus-seropositive donor (p = 0.048), high pulmonary vascular resistance (p = 0.018), and intraaortic balloon pump support (p = 0.03). It also identified a positive B-cell flow cytometry crossmatch (p = 0.015) to be a risk factor with univariate analysis.
Conclusions. Our data identify a group of recipients, reportedly at high risk in multicenter registries, who are not at increased risk of death after Tx. This information supports the growing experience with older donors and recipients and with bridged transplants, and has allowed us to expand our donor pool. These prognostic factors at evaluation allow more liberal selection of patients and donors for transplantation.
This article has been cited by other articles:
![]() |
R. J. Tedford, A. R. Hemnes, S. D. Russell, I. S. Wittstein, M. Mahmud, A. L. Zaiman, S. C. Mathai, D. R. Thiemann, P. M. Hassoun, R. E. Girgis, et al. PDE5A Inhibitor Treatment of Persistent Pulmonary Hypertension After Mechanical Circulatory Support Circ Heart Fail, November 1, 2008; 1(4): 213 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Tjang, G. J.M.G. van der Heijden, G. Tenderich, R. Korfer, and D. E. Grobbee Impact of Recipient's Age on Heart Transplantation Outcome Ann. Thorac. Surg., June 1, 2008; 85(6): 2051 - 2055. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Davies, M. J. Russo, K. N. Hong, M. L. O'Byrne, D. P. Cork, A. J. Moskowitz, A. C. Gelijns, S. Mital, R. S. Mosca, and J. M. Chen The use of mechanical circulatory support as a bridge to transplantation in pediatric patients: an analysis of the United Network for Organ Sharing database. J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 421 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Davies, M. J. Russo, S. Mital, T. M. Martens, R. S. Sorabella, K. N. Hong, A. C. Gelijns, A. J. Moskowitz, J. M. Quaegebeur, R. S. Mosca, et al. Predicting survival among high-risk pediatric cardiac transplant recipients: An analysis of the United Network for Organ Sharing database J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 147 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Etz, H. A. Welp, T. D.T. Tjan, A. Hoffmeier, E. Weigang, H. H. Scheld, and C. Schmid Medically Refractory Pulmonary Hypertension: Treatment With Nonpulsatile Left Ventricular Assist Devices Ann. Thorac. Surg., May 1, 2007; 83(5): 1697 - 1705. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Ganesh, C. A. Rogers, N. R. Banner, R. S. Bonser, and on behalf of the Steering Group Donor cause of death and medium-term survival after heart transplantation: A United Kingdom national study J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1153 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. G. Solomon, J. R. McGiven, P. M. Alison, P. N. Ruygrok, D. A. Haydock, H. A. Coverdale, and T. M. West Changing donor and recipient demographics in a heart transplantation program: influence on early outcome Ann. Thorac. Surg., June 1, 2004; 77(6): 2096 - 2102. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Morgan, R. John, A. D. Weinberg, A. R. Kherani, N. J. Colletti, D. W. Vigilance, F. H. Cheema, G. Bisleri, T. Cosola, D. M. Mancini, et al. Prolonged donor ischemic time does not adversely affect long-term survival in adult patients undergoing cardiac transplantation J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1624 - 1633. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Baron, A. Le Guyader, J. N. Trochu, M. Burban, J. C. Chevalier, M. Treilhaud, T. Petit, O. Al Habash, P. Despins, J. L. Michaud, et al. Does the pretransplant UNOS status modify the short- and long-term cardiac transplant prognosis? Ann. Thorac. Surg., June 1, 2003; 75(6): 1878 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Blanche, D. A. Blanche, B. Kearney, M. Sandhu, L. S. C. Czer, A. Kamlot, A. Hickey, and A. Trento Heart transplantation in patients seventy years of age and older: A comparative analysis of outcome J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 532 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rajek, T. Pernerstorfer, J. Kastner, P. Mares, M. Grabenwoger, D. I. Sessler, G. Grubhofer, and M. Hiesmayr Inhaled Nitric Oxide Reduces Pulmonary Vascular Resistance More Than Prostaglandin E1 During Heart Transplantation Anesth. Analg., March 1, 2000; 90(3): 523 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Sia and R. Patel New Strategies for Prevention and Therapy of Cytomegalovirus Infection and Disease in Solid-Organ Transplant Recipients Clin. Microbiol. Rev., January 1, 2000; 13(1): 83 - 121. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |